Get started
Author

Eva Regina Haspinger

Observed names: E. Haspinger, E.R. Haspinger, EVA HASPINGER, Eva Haspinger, Eva R. Haspinger
OpenAlex ID: A5030632541
Design and development of a peptide-based adiponectin receptor agonist for cancer treatment
2011 · Laszlo Otvos, Eva Haspinger, et al. · BMC Biotechnology · 185
PDF
Targeting the MET gene for the treatment of non-small-cell lung cancer
2013 · F. Gelsomino, F. Facchinetti, et al. · Critical Reviews in Oncology/Hematology · 79
PDF
Targeted therapy-induced diarrhea: A review of the literature
2013 · M.A. Pessi, N. Zilembo, et al. · Critical Reviews in Oncology/Hematology · 58
Is there evidence for different effects among EGFR-TKIs? Systematic review and meta-analysis of EGFR tyrosine kinase inhibitors (TKIs) versus chemotherapy as first-line treatment for patients harboring EGFR mutations
2014 · Eva Regina Haspinger, Francesco Agustoni, et al. · Critical Reviews in Oncology/Hematology · 56
Emerging toxicities in the treatment of non-small cell lung cancer: Ocular disorders
2013 · Francesco Agustoni, Marco Platania, et al. · Cancer Treatment Reviews · 46
PDF
Metformin inhibits leptin-induced growth and migration of glioblastoma cells
2012 · RITA FERLA, EVA HASPINGER, et al. · Oncology Letters · 37
PDF
Activity of the EGFR-HER2 Dual Inhibitor Afatinib in EGFR-Mutant Lung Cancer Patients With Acquired Resistance to Reversible EGFR Tyrosine Kinase Inhibitors
2014 · Lorenza Landi, Marcello Tiseo, et al. · Clinical Lung Cancer · 36
PDF
Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors
2014 · D. Serpico, A. Trama, et al. · Annals of Oncology · 29
PDF
Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a tertiary care hospital in northern Italy
2020 · Dominic Fong, Simon Rauch, et al. · ESMO Open · 19
PDF
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer
2023 · Alessandra Fabi, Luisa Carbognin, et al. · npj Breast Cancer · 18
PDF
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment in Patients With EGFR Wild-Type Non–Small-Cell Lung Cancer: The Never-Ending Story
2013 · Francesco Gelsomino, Francesco Agustoni, et al. · Journal of Clinical Oncology · 17
Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approach
2022 · Caterina Fontanella, Carlo Alberto Giorgi, et al. · Critical Reviews in Oncology/Hematology · 13
PDF
3133 Prognostic value of texture analysis and correlation with molecular profile in EGFR mutated/ALK rearranged advanced non-small cell lung cancer (NSCLC)
2015 · C. Caramella, M.V. Bluthgen, et al. · European Journal of Cancer · 8
Does Immunohistochemistry Affect Response to Therapy and Survival of Inoperable Non–Small Cell Lung Carcinoma Patients? A Survey of 145 Stage III-IV Consecutive Cases
2013 · Giuseppe Pelosi, Eva Regina Haspinger, et al. · International Journal of Surgical Pathology · 8
3127 Prognostic value of texture analysis in advanced non-small cell lung cancer (NSCLC)
2015 · M.V. Bluthgen, C. Caramella, et al. · European Journal of Cancer · 4
Do We Really Need Another Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in First-Line Treatment for Patients With Non–Small-Cell Lung Cancer and EGFR Mutations?
2014 · Eva R. Haspinger, Marina Chiara Garassino, et al. · Journal of Clinical Oncology · 3
PDF
467 Radiomics to identify HER2 amplification or mutation in metastatic patients with solid tumors prospectively enrolled in MOSCATO-01
2015 · E.R. Haspinger, S. Rosellini, et al. · European Journal of Cancer · 2
Fatal case of hepatic portal venous gas following palliative stenting and chemotherapy for occlusive advanced colorectal cancer
2014 · Marco Platania, Barbara Valeri, et al. · International Journal of Colorectal Disease · 2
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer
2023 · Alessandra Fabi, Luisa Carbognin, et al. · npj Breast Cancer · 1
PDF
Update on Therapeutic Strategy in Lung Carcinoids
2013 · Sara Pusceddu, Milena Vitali, et al. · Journal of Cancer Therapy · 1
PDF
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer
2024 · Alessandra Fabi, Luisa Carbognin, et al. · npj Breast Cancer
PDF
Clinical Relevance of Cd133 Positive Cells in Locally Advanced Non-Small Cell Lung Cancer
2014 · E.R. Haspinger, M. Platania, et al. · Annals of Oncology
Works count: 22
Citation count: 622
H-index: 12
I10-index: 12
Year
Topic
Type